Advertisement

Topics

Search Results for "MPM Capital Novartis"

20:22 EDT 30th July 2016 | BioPortfolio

Matching Channels

Matching News

Novartis baut Pharmasparte um - Pharmachef David Epstein geht

Basel (awp) - Der Pharmakonzern Novartis baut seine Pharmasparte um und schafft neu die beiden Geschäftseinheiten Novartis Pharmaceuticals und Novartis Oncology. Diese sind beide Novartis-CEO Josep.....

Novartis Separates Drug Business into Pharmaceuticals, Oncology Divisions

Novartis announced changes to focus its Pharmaceuticals Division by creating two business units reporting to the CEO: Novartis Pharmaceuticals and Novartis Oncology. These business units will form the...

Novartis Venture Funds: How the Funding Model Works

In this episode of PharmaTelevision News Review, Fintan Walton talks with Anja König, Managing Director at Novartis Venture Funds. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: ...

Novartis creates separate pharmaceutical and oncology divisions

Novartis has focussed its pharmaceutical division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology, that will together function as the Innovative Medicine Division at Nov...

Novartis Seen Mulling Roche Share Sale

Novartis is said to be planning to divest its nearly $14 billion stake in rival Swiss drugmaker Roche, accounting for about 6% of that company’s shares and more than 30% of its voting capital, a...

Novartis splits departing exec Shaw's role in two

Novartis AG (NYSE:NVS; SIX:NOVN) promoted two executives to replace Christi Shaw, who will leave the company. She was U.S. country head, president of Novartis Corp. and president of Novartis Pharmaceu...

Novartis cuts pharmaceutical division in half

Novartis has announced changes to focus its Pharmaceuticals Division by creating two business units reporting to the CEO: Novartis Pharmaceuticals and Novartis Oncology. These business units will form...

Novartis fokussiert ihre Division Pharmaceuticals durch Schaffung der Geschäftseinheiten Novartis Pharmaceuticals und Novartis Oncology und beruft deren Leiter in die Geschäftsleitung von Novartis

Paul Hudson wird zum CEO, Novartis Pharmaceuticals, und Bruno Strigini zum CEO, Novartis Oncology, ernannt; David Epstein wird Novartis verlassen Paul Hudson und Bruno Strigini werden in die Gesch...

Matching PubMed Articles

Relationship between social capital indicators and lifestyle in Brazilian adults.

The present study examined the relationship between indicators of social capital and health-related behaviors. A cross-sectional study was conducted on a sample of 1,062 participants representative of...

Individual Cognitive Social Capital and Its Relationship with Pain and Sick Leave Due to Pain in the Austrian Population.

Individual cognitive social capital has repeatedly been shown to be linked to health disparities in many dimensions. The aim of the study was to investigate the association between social capital and ...

Role of Livelihood Capital in Reducing Climatic Vulnerability: Insights of Australian Wheat from 1990-2010.

In many agricultural countries, development of rural livelihood through increasing capital is a major regional policy to adapt to climate change. However, the role of livelihood capital in reducing cl...

How does social capital matter to the health status of older adults? Evidence from the China Health and Retirement Longitudinal Survey.

This paper uses longitudinal data from China to examine the causal relationship between structural social capital and health among Chinese older adults. We employ various econometric strategies to con...

Are Forensic Experts Already Biased before Adversarial Legal Parties Hire Them?

This survey of 206 forensic psychologists tested the "filtering" effects of preexisting expert attitudes in adversarial proceedings. Results confirmed the hypothesis that evaluator attitudes toward ca...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement